Teligen was cleared for minimally invasive transforaminal lumbar interbody fusion, according to a news release. The system delivers technologies including camera controls, a VueLIF-T procedure kit, a Teligen clear discectomy device and patient-based disposable ports.
Teligen integrates with the Unleash family of implants, which are designed to streamline the main stages of MIS-TLIF.
The system is expected to be available later in 2022. DePuy Synthes is the orthopedics company for Johnson & Johnson.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.